We are discovery rich, but development poor
G.V. Prasad has spent over thirty years at the helm of Dr. Reddy\'s Laboratories — long enough to know where the oppor...
G.V. Prasad has spent over thirty years at the helm of Dr. Reddy\'s Laboratories — long enough to know where the oppor...
G.V. Prasad has spent over thirty years at the helm of Dr. Reddy\'s Laboratories — long enough to know where the oppor...
G.V. Prasad has spent over thirty years at the helm of Dr. Reddy\'s Laboratories — long enough to know where the oppor...
Zydus Lifesciences is set to launch a generic version of the weight-loss injection semaglutide next month. The drug will...
Zydus Lifesciences has achieved a significant milestone by obtaining tentative approval from the US FDA for Dapagliflozi...
Drug firm Lupin has launched a generic cancer treatment medication in the US. The company introduced Dasatinib Tablets i...
Indoco Remedies has secured approval from the US health regulator for its generic Lacosamide oral solution. This medicat...